24 Recruiting Plaque Psoriasis Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Browse by Study Phase
Top Interventions for Plaque Psoriasis
Top Recruiting Plaque Psoriasis Studies
A Study of JNJ-77242113 in Adolescent and Adult Participants With Moderate to Severe Plaque Psoriasis
📍 Medical Dermatology Specialists — Phoenix, Arizona
View Study & Checklist ➔Dose Ranging Study of ORKA-001 in Patients With Moderate-to-Severe Plaque Psoriasis
📍 Oruka Therapeutics Investigative Site — Phoenix, Arizona
View Study & Checklist ➔A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis
📍 Total Dermatology — Birmingham, Alabama
View Study & Checklist ➔Tapinarof for the Treatment of Plaque Psoriasis in Pediatric Subjects
📍 Northwest Arkansas Clinical Trials Center, PLLC — Rogers, Arkansas
View Study & Checklist ➔Open-Label Extension Study to Evaluate the Long Term Safety and Efficacy of ESK-001 in Plaque Psoriasis
📍 Investigator Site # 1029 — Birmingham, Alabama
View Study & Checklist ➔A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis (ICONIC-ADVANCE 2)
📍 Alliance Dermatology and MOHS Center P C — Phoenix, Arizona
View Study & Checklist ➔A Study of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis
📍 Medical Dermatology Specialists — Phoenix, Arizona
View Study & Checklist ➔A Study to Assess Efficacy and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab in Participants With Moderate to Severe Plaque Psoriasis
📍 Cahaba Research Inc — Birmingham, Alabama
View Study & Checklist ➔ORKA-001 Versus Placebo in Patients With Moderate-to-Severe Plaque Psoriasis
📍 Oruka Therapeutics Investigative Site — Fountain Valley, California
View Study & Checklist ➔A Study of JNJ-77242113 for the Treatment of Participants With Plaque Psoriasis Involving Special Areas (Scalp, Genital, and/or Palms of the Hands and the Soles of the Feet)
📍 Center for Dermatology and Plastic Surgery — Scottsdale, Arizona
View Study & Checklist ➔Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis
📍 Total Dermatology — Birmingham, Alabama
View Study & Checklist ➔Understanding Participation Habits Among Plaque Psoriasis Patients
📍 Power Life Sciences — San Francisco, California
View Study & Checklist ➔Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
📍 Local Institution - 0088 — Birmingham, Alabama
View Study & Checklist ➔Dose Ranging Study of ORKA-002 in Patients With Moderate-to-Severe Plaque Psoriasis
📍 Oruka Therapeutics Investigative Site — Birmingham, Alabama
View Study & Checklist ➔A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis
📍 Exalt Clinical Research — Chula Vista, California
View Study & Checklist ➔A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of ASC50 Tables in Healthy Participants and Participants With Plaque Psoriasis
📍 Ascletis Clinical Site — Miami, Florida
View Study & Checklist ➔A Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Children and Adolescent Participants With Moderate to Severe Plaque Psoriasis
📍 Instituto de Neumonologia Y Dermatologia — Ciudad Autonoma de Buenos Aires, Buenos Aires
View Study & Checklist ➔An Open-Label Extension Study of ORKA-001 in Participants With Plaque Psoriasis
📍 Oruka Therapeutics Investigative Site — Fountain Valley, California
View Study & Checklist ➔Modifying PEST for Psoriatic Arthritis Screening
📍 Novartis Investigative Site — Calgary, Alberta
View Study & Checklist ➔Triamcinolone With Vitamin D Synergistic Efficacy in Psoriasis
📍 Wright State Physicians — Fairborn, Ohio
View Study & Checklist ➔A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
📍 Local Institution - 0261 — Birmingham, Alabama
View Study & Checklist ➔Study to Assess Change in Quality of Life of Risankizumab Treatment in Adult Participants With Moderate-to-Severe Plaque Psoriasis
📍 Dermatology Research Institute - Blackfoot Trail /ID# 276722 — Calgary, Alberta
View Study & Checklist ➔